NL-OMON36837已完成不适用
An open label, single oral dose study to investigate the pharamcokinetics - absorption, distribution, metabolism, and elimination - of 75 mg of 14C-labeled BCT197 in healthy male volunteers. - BCT197 ADME study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- ovartis
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male volunteers
- •18-45 years, inclusive
- •BMI: 18-30 kg/m2, inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 month prior to the start of this study
研究者
相似试验
招募中
1 期
An Open-label, Single-Dose Study to Investigate the Pharmacokinetics of KSP-1007 in Healthy Adult Chinese SubjectsHospital-acquired pneumonia including ventilator-associated pneumoniaJPRN-jRCT2071230099Tsukada Hironobu32
已完成
不适用
An open-label and single-dosing study to evaluate the safety, pharmacokinetics and food effect of UI026 in healthy male volunteers.KCT0003451Chungnam National University Hospital12
已完成
1 期
An open-label, multiple oral dose study to explore the pharmacokinetic and pharmacodynamic profiles of 0.5mg colchicine in healthy male adult volunteersCoronary artery diseaseJPRN-UMIN000018042Clinical Trial Center, Kitasato University Hospital8
已完成
1 期
Mass balance study of [14C]-REN001 in healthy male subjectsPrimary mitochondrial myopathy (rare genetic diseases that cause muscles to not function properly)Genetic DiseasesISRCTN57533271Reneo Pharma Ltd6
进行中（未招募）
1 期
Study on parathyroid hormone for use in hypoparathyroidism in children 12 to less than 18 years old.EUCTR2015-003108-22-GBPS Pharmaceuticals, Inc.10